As of close of business last night, Tenaya Therapeutics Inc’s stock clocked out at $4.59, down -8.02% from its previous closing price of $4.99. In other words, the price has decreased by -$0.4000 from its previous closing price. On the day, 632819 shares were traded.
Ratios:
To gain a deeper understanding of TNYA’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.91 and its Current Ratio is at 4.91. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.06.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Leerink Partners on November 30, 2023, initiated with a Outperform rating and assigned the stock a target price of $7.
On June 15, 2022, H.C. Wainwright started tracking the stock assigning a Buy rating and target price of $25.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 05 ’24 when Hoey Timothy sold 3,300 shares for $7.00 per share. The transaction valued at 23,101 led to the insider holds 245,346 shares of the business.
Hoey Timothy sold 6,569 shares of TNYA for $35,046 on Feb 20 ’24. The Chief Scientific Officer now owns 236,146 shares after completing the transaction at $5.34 per share. On Feb 16 ’24, another insider, Tingley Whittemore, who serves as the Chief Medical Officer of the company, sold 6,500 shares for $5.86 each. As a result, the insider received 38,090 and left with 73,534 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TNYA now has a Market Capitalization of 360.39M and an Enterprise Value of 268.17M.
Stock Price History:
Over the past 52 weeks, TNYA has reached a high of $8.09, while it has fallen to a 52-week low of $1.66. The 50-Day Moving Average of the stock is 5.2591, while the 200-Day Moving Average is calculated to be 3.7522.
Shares Statistics:
It appears that TNYA traded 623.09K shares on average per day over the past three months and 452.94k shares per day over the past ten days. A total of 68.33M shares are outstanding, with a floating share count of 61.92M. Insiders hold about 21.14% of the company’s shares, while institutions hold 45.79% stake in the company. Shares short for TNYA as of Mar 15, 2024 were 2.55M with a Short Ratio of 4.10, compared to 2.48M on Feb 15, 2024. Therefore, it implies a Short% of Shares Outstanding of 3.25% and a Short% of Float of 4.48%.
Earnings Estimates
As of right now, 7 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$0.42 for the current quarter, with a high estimate of -$0.4 and a low estimate of -$0.45, while EPS last year was -$0.43. The consensus estimate for the next quarter is -$0.43, with high estimates of -$0.36 and low estimates of -$0.5.
Analysts are recommending an EPS of between -$1.47 and -$1.91 for the fiscal current year, implying an average EPS of -$1.74. EPS for the following year is -$1.81, with 6 analysts recommending between -$1.36 and -$2.25.
